Safety and Efficacy of Denosumab for Fibrous Dysplasia of Bone.
作者信息
de Castro Luis F, Michel Zachary, Pan Kristen, Taylor Jocelyn, Szymczuk Vivian, Paravastu Sriram, Saboury Babak, Papadakis Georgios Z, Li Xiaobai, Milligan Kelly, Boyce Brendan, Paul Scott M, Collins Michael T, Boyce Alison M
机构信息
National Institutes of Health, Bethesda, MD.
Foundation for Research and Technology, Heraklion, Greece.
出版信息
N Engl J Med. 2023 Feb 23;388(8):766-768. doi: 10.1056/NEJMc2214862.
Abstract
摘要
相似文献
1
Safety and Efficacy of Denosumab for Fibrous Dysplasia of Bone.地诺单抗治疗骨纤维发育不良的安全性和有效性。
N Engl J Med. 2023 Feb 23;388(8):766-768. doi: 10.1056/NEJMc2214862.
2
Successful treatment with denosumab for pelvic fibrous dysplasia: A case report and review of the literature.成功使用地舒单抗治疗骨盆纤维结构不良：病例报告及文献复习。
Medicine (Baltimore). 2021 Dec 10;100(49):e28138. doi: 10.1097/MD.0000000000028138.
3
Denosumab for Fibrous Dysplasia: Promising, but Questions Remain.地诺单抗治疗骨纤维异常增殖症：前景可期，但仍存疑问。
J Clin Endocrinol Metab. 2020 Nov 1;105(11):e4179-80. doi: 10.1210/clinem/dgaa091.
4
Denosumab Treatment for Giant Cell Tumors, Aneurysmal Bone Cysts, and Fibrous Dysplasia-Risks and Benefits.地舒单抗治疗巨细胞瘤、动脉瘤样骨囊肿和纤维结构不良——风险与获益。
Curr Osteoporos Rep. 2021 Apr;19(2):141-150. doi: 10.1007/s11914-021-00657-z. Epub 2021 Feb 22.
5
Letter regarding - Denosumab use in bone fibrous dysplasia refractory to bisphosphonate: A retrospective multicentric study.关于地诺单抗治疗对双膦酸盐难治的骨纤维异常增殖症的信函：一项回顾性多中心研究
Bone. 2023 Oct;175:116853. doi: 10.1016/j.bone.2023.116853. Epub 2023 Jul 18.
6
Rapid biochemical response to denosumab in fibrous dysplasia of bone: report of two cases.骨纤维异常增殖症中地诺单抗的快速生化反应：两例报告
Osteoporos Int. 2014 Feb;25(2):777-82. doi: 10.1007/s00198-013-2585-1. Epub 2013 Dec 6.
7
Denosumab Use in Adults With Fibrous Dysplasia: Case Reports and Review of the Literature.地舒单抗在纤维结构不良成人患者中的应用：病例报告及文献复习。
Endocr Pract. 2022 Nov;28(11):1196-1201. doi: 10.1016/j.eprac.2022.07.012. Epub 2022 Aug 8.
8
Fibrous dysplasia. Clinical review and therapeutic management.骨纤维异常增殖症。临床综述与治疗管理。
Med Clin (Barc). 2016 Dec 16;147(12):547-553. doi: 10.1016/j.medcli.2016.07.030. Epub 2016 Oct 17.
9
Denosumab usage in atypical cemento-osseous dysplasia involving the entire mandible: a case report.地诺单抗在累及整个下颌骨的非典型水泥骨发育异常中的应用：一例报告
BMC Oral Health. 2025 Jan 30;25(1):164. doi: 10.1186/s12903-025-05514-4.
10
Treatment of fibrous dysplasia: focus on denosumab.骨纤维异常增殖症的治疗：聚焦地诺单抗
Expert Opin Biol Ther. 2022 Mar;22(3):397-405. doi: 10.1080/14712598.2022.2022118. Epub 2021 Dec 29.
引用本文的文献
1
Burosumab treatment for fibroblast growth factor-23-associated hypophosphatemia in an adult patient with severe fibrous dysplasia in McCune-Albright syndrome: case report and review of the literature.布罗索尤单抗治疗McCune-Albright综合征伴严重纤维性发育不良成年患者的成纤维细胞生长因子23相关低磷血症：病例报告及文献复习
JBMR Plus. 2025 Jul 25;9(9):ziaf125. doi: 10.1093/jbmrpl/ziaf125. eCollection 2025 Sep.
2
Fibrous dysplasia/McCune-Albright syndrome: state-of-the-art advances, pathogenesis, and basic/translational research.纤维发育不良/麦库恩-奥尔布赖特综合征：最新进展、发病机制及基础/转化研究
Orphanet J Rare Dis. 2025 Aug 8;20(1):414. doi: 10.1186/s13023-025-03909-8.
3
Protein kinase A is a dependent factor and therapeutic target in mouse models of fibrous dysplasia.蛋白激酶A是纤维发育不良小鼠模型中的一个依赖因子和治疗靶点。
Nat Commun. 2025 Jul 1;16(1):5425. doi: 10.1038/s41467-025-61402-z.
4
McCune-Albright syndrome: a case of an adult with fibrous dysplasia, severe cardiopulmonary complications, acromegaly, and chronic myeloid leukemia.McCune-Albright综合征：一例患有纤维性发育异常、严重心肺并发症、肢端肥大症和慢性粒细胞白血病的成人病例。
JBMR Plus. 2025 May 18;9(7):ziaf090. doi: 10.1093/jbmrpl/ziaf090. eCollection 2025 Jul.
5
Update on the medical management of fibrous dysplasia of the bone.骨纤维异常增殖症的药物治疗进展
Ther Adv Endocrinol Metab. 2025 Jun 18;16:20420188251347350. doi: 10.1177/20420188251347350. eCollection 2025.
6
Use of burosumab in McCune Albright syndrome: case report and review of literature in mosaic disorders with FGF23 overproduction.布罗索尤单抗在麦库恩-奥尔布赖特综合征中的应用：病例报告及对FGF23过度产生的嵌合性疾病的文献综述
Front Endocrinol (Lausanne). 2025 May 26;16:1577734. doi: 10.3389/fendo.2025.1577734. eCollection 2025.
7
A mouse model of Jansen's metaphyseal chondrodysplasia for investigating disease mechanisms and candidate therapeutics.用于研究疾病机制和候选治疗方法的詹森干骺端软骨发育不良小鼠模型。
Proc Natl Acad Sci U S A. 2025 Jun 10;122(23):e2500176122. doi: 10.1073/pnas.2500176122. Epub 2025 Jun 2.
8
Rare genetic skeletal disorders: Evolving terminology, therapies, education and advocacy.罕见遗传性骨骼疾病：不断发展的术语、治疗方法、教育与宣传。
J Pediatr Soc North Am. 2024 Apr 10;7:100057. doi: 10.1016/j.jposna.2024.100057. eCollection 2024 May.
9
No overshoot of bone turnover after withdrawal of denosumab treatment of adults with Langerhans cell histiocytosis: a prospective clinical trial.成人朗格汉斯细胞组织细胞增多症患者停用地诺单抗治疗后骨转换无过度现象：一项前瞻性临床试验
Osteoporos Int. 2025 May 26. doi: 10.1007/s00198-025-07538-6.
10
Developing a Standardised Dataset for Natural History Studies in Fibrous Dysplasia/McCune-Albright Syndrome.为纤维发育不良/麦库恩-奥尔布赖特综合征的自然史研究开发标准化数据集。
Calcif Tissue Int. 2025 May 2;116(1):68. doi: 10.1007/s00223-025-01379-5.
本文引用的文献
1
Denosumab Reduces Lesional Fluoride Skeletal Burden on Na[18F]F PET-CT in Patients With Fibrous Dysplasia/McCune-Albright Syndrome.地舒单抗可降低纤维结构不良/ McCune-Albright 综合征患者病灶氟骨放射性核素摄取 PET-CT 中的氟骨放射性核素摄取。
J Clin Endocrinol Metab. 2021 Jul 13;106(8):e2980-e2994. doi: 10.1210/clinem/dgab212.
2
F-NaF PET/CT IMAGING IN FIBROUS DYSPLASIA OF BONE.骨纤维结构不良的 F-NaF PET/CT 影像学表现。
J Bone Miner Res. 2019 Sep;34(9):1619-1631. doi: 10.1002/jbmr.3738. Epub 2019 May 22.
3
Activation of RANK/RANKL/OPG Pathway Is Involved in the Pathophysiology of Fibrous Dysplasia and Associated With Disease Burden.RANK/RANKL/OPG 通路的激活与纤维结构不良的病理生理学有关，并与疾病负担相关。
J Bone Miner Res. 2019 Feb;34(2):290-294. doi: 10.1002/jbmr.3602. Epub 2018 Nov 29.
4
Denosumab treatment for fibrous dysplasia.地舒单抗治疗纤维结构不良。
J Bone Miner Res. 2012 Jul;27(7):1462-70. doi: 10.1002/jbmr.1603.
5
The histopathology of fibrous dysplasia of bone in patients with activating mutations of the Gs alpha gene: site-specific patterns and recurrent histological hallmarks.Gsα基因激活突变患者骨纤维发育不良的组织病理学：部位特异性模式和复发性组织学特征
J Pathol. 1999 Jan;187(2):249-58. doi: 10.1002/(SICI)1096-9896(199901)187:2<249::AID-PATH222>3.0.CO;2-J.
Zotero 插件